InnoCare (诺诚健华) Pre-IPO: PHIP and Valuation Update
InnoCare Pharma Limited is a clinical-stage biopharmaceutical company with a focus on small molecule inhibitors for BTK, and FGFRs. The company...
501 Views
InnoCare (诺诚健华) Pre-IPO: Thoughts on Valuation
InnoCare Pharma Limited is a clinical-stage biopharmaceutical company with a focus on small molecule inhibitors for BTK, and FGFRs. The company...
501 Views
Aequitas 2019 IPOs and Placements Performance - Things We Got Right/Wrong and Things We Plan to Do
2019 marked our first full year of operations as an Independent Research Company, post spin-off from Smartkarma in August 2018. With our...
596 Views
SinoMab (中国抗体) Post-IPO Trading: Decent Retail Interests Can't Save the Day
SinoMab's IPO was priced at the low end and started trading today. We have highlighted in our earlier note that 1) the company's core product...
373 Views
ECM Weekly (9 Nov 2019) - Phoenix Tree, I-Mab, Tyro Payments, Pharmaron, Heaven-Sent
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong Kong...
457 Views